Is the correction over?
We have been seeing a brutal selloff/shorting since mid-February of this year - especially within the genomics sectors, a darling sector for ARKK investments. This is one of their highest conviction names. The chart is indicating a possible near-term bottom per the formation of a long-term trendline and sentiment slowly shifting with more buying volume this week.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.